3 Canadian Cannabis Unicorns To Watch

The legal marijuana industry continues to be the fastest growing industry in the world and this trend has shown no signs of slowing down as countries around the world continue to get on the legal marijuana train.

Although the marijuana industry presents a lot of hype, it has been able to live up to the high expectations. Legal marijuana remains a controversial topic (in some circles) and some investors are missing out on a once in a lifetime opportunity.

A Multi-Billion-Dollar Opportunity

The emergence of the legal marijuana industry has created an entire new sector of the stock market. The number of publicly traded cannabis companies has seen exponential growth since 2014 as, 400+ publicly traded companies now claim to be cannabis businesses.

Although the legal marijuana industry has proven to be a very profitable opportunity for some investors, many have not fared as well. We continue to recommend that investors focus on companies that are led by a proven management team, are well capitalized, continue to execute on their business plan, and act in the best interest of shareholders.

The legal marijuana industry reached a milestone this week and there are now three companies that have a market capitalization above $1 billion. This is a significant development for an industry that is still in the first inning of a multi-decade growth cycle and we want to highlight the three companies that have accomplished this feat.

Aurora Cannabis Inc. (ACB.TO) (ACBFF)

Aurora Cannabis Inc. has been making waves in the global marijuana industry and is an industry leader. From Australia to Germany, this Canadian licensed producer has significantly increased its market share and is levered to new legal cannabis markets across the globe.

Aurora has one of the strongest balance sheets when compared to its peers and is levered to several emerging growth trends throughout the world. Aurora has more than 19,000 registered patients in Canada. We are favorable on the company’s leverage to other legal markets and see it as a company to watch.

Canopy Growth Corp (WEED.TO) (TWMJF)

Canopy Growth Corp is by far the largest and most diverse licensed Canadian medical marijuana producer. The company is comprised of several wholly‑owned subsidiaries and has increased its reach by making investments in and acquisitions of companies all over the globe.

Canopy Growth was the first publicly traded licensed Canadian medical marijuana producer and has a greater breadth of multi-site management than any other cannabis firm in the world. The company has a very strong balance sheet and has penetrated new international markets. With more than 58,000 Canadian customers on its online store, Canopy possesses some of the most attractive growth prospects and we expect the company to continue to be a leader for years to come.

MedReleaf Corp. (LEAF.TO) (MEDFF)

MedReleaf Corp., Canada’s first and only ISO 9001 and ICH-GMP certified cannabis producer, conducted its initial public offering (IPO) in early June and the shares have rallied more than 50% since then.

This Canadian medical marijuana producer has been putting up strong numbers and reported more than $10 million in revenue during the first quarter. MedReleaf has benefited from a consumer trend toward smokeless cannabis products and was the first licensed producer to launch a topical cream.

MedReleaf has been capitalizing on international opportunities and completed its first commercial cannabis-based pharmaceutical export to a patient in Brazil in July. The licensed producer is also focused on the Australian and German marijuana markets and we are favorable on the company’s long-term opportunity.